A U of M edtech startup's acquisition was among the most noteworthy stories to hit the Minnesota startup scene this year.
A U of M startup was named among the companies with the highest fundraising rounds this year.
Calyxt, a food and agriculture startup based on U of M research, recently received a European patent to create gene-edited plants by the transient delivery of sequence-specific nucleases, including CRISPR/Cas9.
U of M startup Vascudyne Inc. manufactures organic arteries and heart valves that can live and grow within the body.
Bates, who was nominated for the award in part by U of M Technology Commercialization, holds 26 US and numerous foreign patents in the field of polymer science.
A recently launched U of M startup is developing tissue for medical device and therapeutics applications.
A new, gene-edited soybean oil developed at the U of M is among the next generation of biotech food.
A U startup company is studying whether a flexible pneumatic tube could help remove invasive carp from the state's lakes and marshes.
The U of M licensed its eye scanning system for early Alzheimer's detection to RetiSpec, a medical imaging company.
The U of M and the Medical Alley Association hosted representatives of the US Department of Health and Human Services for "Healthcare Startup Day Minnesota."
Sign up for the UMN Research newsletter >